Table 4. Mutation and bone marrow of patients with essential thrombocythemia (n= 17).
| Parameters | n (%) |
|---|---|
| Mutation | |
| JAK2V617 | 15 (88.23) |
| CALR exon 9 | 2 (11.76) |
| MPL exon 10 | - |
| Bone marrow | |
| Megakaryocyte proliferation | 14 (82.35) |
| Normal | 3 (17.64) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.